BOLTON SECURITIES CORPORATION’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.67K Buy
27
+19
+238% +$2.29K ﹤0.01% 2065
2026
Q2
$1.07K Buy
+8
New +$905 ﹤0.01% 2138

Other funds holding ABVX

BOLTON SECURITIES CORPORATION's ABVX Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Abivax (ABVX) stake by 238% in Q3 2026, buying an estimated $2.29K and bringing the position to 27 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

BOLTON SECURITIES CORPORATION first reported a position in ABVX in Q2 2026 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 27 shares of Abivax worth $2.67K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 19 Abivax shares in Q3 2026, an estimated $2.29K.
  • Abivax made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #2065 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Abivax in Q2 2026 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.